Please enable JavaScript to continue using this application.

Compare $ABEO vs $PRLD | Chartloom

Compare

$ABEO vs $PRLD

Abeona Therapeutics Inc · Prelude Therapeutics Inc

ABEO

Abeona Therapeutics Inc

PRLD

Prelude Therapeutics Inc

Compare $ABEO vs $PRLD

Comparing Abeona Therapeutics Inc and Prelude Therapeutics Inc

ABEOAbeona Therapeutics Inc

PRLDPrelude Therapeutics Inc

ABEOAbeona Therapeutics Inc

Market cap

$282M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.20x

Rev growth (TTM)

6280.0%

YTD performance

-7.0%

52W performance

-10.8%

FCF yield

-29.0%

PRLDPrelude Therapeutics Inc

Market cap

$310M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.94x

Rev growth (TTM)

—

YTD performance

42.5%

52W performance

173.9%

FCF yield

-10.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABEO

PRLD

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

PRLD

Prelude Therapeutics Inc

Market Cap

ABEO$282M

PRLD$310M

Enterprise Value

ABEO$240M

PRLD$284M

Price

ABEO$4.94

PRLD$3.89

P/E Ratio

ABEON/A

PRLDN/A

P/S Ratio

ABEO11.03x

PRLD13.82x

EV/Sales

ABEO9.42x

PRLD12.64x

EV/EBITDA

ABEO3.95x

PRLD0.00x

P/B Ratio

ABEO2.25x

PRLD2.19x

P/FCF Ratio

ABEON/A

PRLDN/A

EV/FCF

ABEO-2.95x

PRLD-8.53x

PEG Ratio

ABEON/A

PRLDN/A

Forward P/E (NTM)

ABEON/A

PRLDN/A

Forward P/S (NTM)

ABEO3.20x

PRLD5.94x

Revenue (TTM)

ABEO$26M

PRLD$22M

Revenue Growth (YoY)

ABEO6280.0%

PRLDN/A

Forward Rev Growth

ABEO131.0%

PRLD-14.3%

Gross Margin (TTM)

ABEO67.1%

PRLD0.0%

Operating Margin (TTM)

ABEO0.0%

PRLD0.0%

EBITDA Margin (TTM)

ABEO-316.6%

PRLD-293.5%

Net Margin (TTM)

ABEO-246.4%

PRLD-269.7%

FCF Margin (TTM)

ABEO-319.5%

PRLD-148.3%

Net Income (TTM)

ABEO$-63M

PRLD$-60M

FCF (TTM)

ABEO$-82M

PRLD$-33M

EPS (TTM)

ABEO-$1.10

PRLD-$0.61

ROE (TTM)

ABEO-4169.0%

PRLD-7535.0%

ROA (TTM)

ABEO-3036.0%

PRLD-4439.0%

ROIC (TTM)

ABEO-3719.0%

PRLD-7535.0%

Cash

ABEO$56M

PRLD$26M

Debt

ABEO$15M

PRLD$0

Net Cash/Debt

ABEO$41M

PRLD$26M

Current Ratio (TTM)

ABEO6.63x

PRLD4.07x

Quick Ratio (TTM)

ABEO6.32x

PRLD3.99x

Debt/Equity (TTM)

ABEO0.12x

PRLD0.00x

Debt/Assets (TTM)

ABEO0.0%

PRLD0.0%

Interest Coverage (TTM)

ABEON/A

PRLDN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

PRLD0.00x

Beta

ABEO1.45

PRLD1.19

52W Performance

ABEO-10.8%

PRLD173.9%

YTD Performance

ABEO-7.0%

PRLD42.5%

% from 52W High

ABEO-35.4%

PRLD-43.0%

% from 52W Low

ABEO23.5%

PRLD238.3%

Asset Turnover (TTM)

ABEO0.13x

PRLD0.16x

FCF Yield (TTM)

ABEO-29.0%

PRLD-10.7%

Earnings Yield (TTM)

ABEO-22.3%

PRLD-19.5%

Dividend Yield (TTM)

ABEON/A

PRLDN/A

Rule of 40

ABEO5,960.5

PRLD-148.3

EV/GP/RG

ABEO0.04

PRLDN/A

Ticker research

View ABEO research View PRLD research

Metric	ABEO Abeona Therapeutics Inc	PRLD Prelude Therapeutics Inc
Market & Valuation
Market Cap	$282M	$310M
Enterprise Value	$240M	$284M
Price	$4.94	$3.89
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	13.82x
EV/Sales	9.42x	12.64x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-8.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	5.94x
Revenue & Growth
Revenue (TTM)	$26M	$22M
Revenue Growth (YoY)	6280.0%	N/A
Forward Rev Growth	131.0%	-14.3%
Profitability
Gross Margin (TTM)	67.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	-293.5%
Net Margin (TTM)	-246.4%	-269.7%
FCF Margin (TTM)	-319.5%	-148.3%
Net Income (TTM)	$-63M	$-60M
FCF (TTM)	$-82M	$-33M
EPS (TTM)	-$1.10	-$0.61
ROE (TTM)	-4169.0%	-7535.0%
ROA (TTM)	-3036.0%	-4439.0%
ROIC (TTM)	-3719.0%	-7535.0%
Financial Health
Cash	$56M	$26M
Debt	$15M	$0
Net Cash/Debt	$41M	$26M
Current Ratio (TTM)	6.63x	4.07x
Quick Ratio (TTM)	6.32x	3.99x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	1.19
52W Performance	-10.8%	173.9%
YTD Performance	-7.0%	42.5%
% from 52W High	-35.4%	-43.0%
% from 52W Low	23.5%	238.3%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.16x
FCF Yield (TTM)	-29.0%	-10.7%
Earnings Yield (TTM)	-22.3%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	-148.3
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View PRLD research

Valuation

P/S Ratio

ABEO

11.03x

PRLD

13.82x

EV/FCF

PRLD

-8.53x

ABEO

-2.95x

Growth & revenue

Revenue Growth TTM

ABEO

6280.0%

Forward Revenue Growth

ABEO

131.0%

PRLD

-14.3%

Profitability & performance

Gross Margin

ABEO

67.1%

PRLD

0.0%

ROE

ABEO

-4169.0%

PRLD

-7535.0%

FCF Yield %

PRLD

-10.7%

ABEO

-29.0%

52-Week Performance

PRLD

173.9%

ABEO

-10.8%

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

PRLD

Prelude Therapeutics Inc

Market Cap

ABEO$282M

PRLD$310M

Enterprise Value

ABEO$240M

PRLD$284M

Price

ABEO$4.94

PRLD$3.89

P/E Ratio

ABEON/A

PRLDN/A

P/S Ratio

ABEO11.03x

PRLD13.82x

EV/Sales

ABEO9.42x

PRLD12.64x

EV/EBITDA

ABEO3.95x

PRLD0.00x

P/B Ratio

ABEO2.25x

PRLD2.19x

P/FCF Ratio

ABEON/A

PRLDN/A

EV/FCF

ABEO-2.95x

PRLD-8.53x

PEG Ratio

ABEON/A

PRLDN/A

Forward P/E (NTM)

ABEON/A

PRLDN/A

Forward P/S (NTM)

ABEO3.20x

PRLD5.94x

Revenue (TTM)

ABEO$26M

PRLD$22M

Revenue Growth (YoY)

ABEO6280.0%

PRLDN/A

Forward Rev Growth

ABEO131.0%

PRLD-14.3%

Gross Margin (TTM)

ABEO67.1%

PRLD0.0%

Operating Margin (TTM)

ABEO0.0%

PRLD0.0%

EBITDA Margin (TTM)

ABEO-316.6%

PRLD-293.5%

Net Margin (TTM)

ABEO-246.4%

PRLD-269.7%

FCF Margin (TTM)

ABEO-319.5%

PRLD-148.3%

Net Income (TTM)

ABEO$-63M

PRLD$-60M

FCF (TTM)

ABEO$-82M

PRLD$-33M

EPS (TTM)

ABEO-$1.10

PRLD-$0.61

ROE (TTM)

ABEO-4169.0%

PRLD-7535.0%

ROA (TTM)

ABEO-3036.0%

PRLD-4439.0%

ROIC (TTM)

ABEO-3719.0%

PRLD-7535.0%

Cash

ABEO$56M

PRLD$26M

Debt

ABEO$15M

PRLD$0

Net Cash/Debt

ABEO$41M

PRLD$26M

Current Ratio (TTM)

ABEO6.63x

PRLD4.07x

Quick Ratio (TTM)

ABEO6.32x

PRLD3.99x

Debt/Equity (TTM)

ABEO0.12x

PRLD0.00x

Debt/Assets (TTM)

ABEO0.0%

PRLD0.0%

Interest Coverage (TTM)

ABEON/A

PRLDN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

PRLD0.00x

Beta

ABEO1.45

PRLD1.19

52W Performance

ABEO-10.8%

PRLD173.9%

YTD Performance

ABEO-7.0%

PRLD42.5%

% from 52W High

ABEO-35.4%

PRLD-43.0%

% from 52W Low

ABEO23.5%

PRLD238.3%

Asset Turnover (TTM)

ABEO0.13x

PRLD0.16x

FCF Yield (TTM)

ABEO-29.0%

PRLD-10.7%

Earnings Yield (TTM)

ABEO-22.3%

PRLD-19.5%

Dividend Yield (TTM)

ABEON/A

PRLDN/A

Rule of 40

ABEO5,960.5

PRLD-148.3

EV/GP/RG

ABEO0.04

PRLDN/A

Ticker research

View ABEO research View PRLD research

Metric	ABEO Abeona Therapeutics Inc	PRLD Prelude Therapeutics Inc
Market & Valuation
Market Cap	$282M	$310M
Enterprise Value	$240M	$284M
Price	$4.94	$3.89
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	13.82x
EV/Sales	9.42x	12.64x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-8.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	5.94x
Revenue & Growth
Revenue (TTM)	$26M	$22M
Revenue Growth (YoY)	6280.0%	N/A
Forward Rev Growth	131.0%	-14.3%
Profitability
Gross Margin (TTM)	67.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	-293.5%
Net Margin (TTM)	-246.4%	-269.7%
FCF Margin (TTM)	-319.5%	-148.3%
Net Income (TTM)	$-63M	$-60M
FCF (TTM)	$-82M	$-33M
EPS (TTM)	-$1.10	-$0.61
ROE (TTM)	-4169.0%	-7535.0%
ROA (TTM)	-3036.0%	-4439.0%
ROIC (TTM)	-3719.0%	-7535.0%
Financial Health
Cash	$56M	$26M
Debt	$15M	$0
Net Cash/Debt	$41M	$26M
Current Ratio (TTM)	6.63x	4.07x
Quick Ratio (TTM)	6.32x	3.99x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	1.19
52W Performance	-10.8%	173.9%
YTD Performance	-7.0%	42.5%
% from 52W High	-35.4%	-43.0%
% from 52W Low	23.5%	238.3%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.16x
FCF Yield (TTM)	-29.0%	-10.7%
Earnings Yield (TTM)	-22.3%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	-148.3
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View PRLD research